George Lamprinidis (George Lambrinidis)

Loop profile Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 19

Top Venues

Journal of medicinal chemistry

Molecules (Basel, Switzerland)

Bioengineering (Basel, Switzerland)

Molecular microbiology

National and Kapodistrian University of Athens

National and Kapodistrian University of Athens (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens May 01 2015

Greece

Laboratory/Educational Staff :: Department of Pharmacy

Chemotargets May 01 2014 - Apr 30 2015

Spain

Post Doctoral Researcher :: Research

National and Kapodistrian University of Athens Sep 20 2009

Greece

Researcher-Administrative staff :: Department of Pharmacy

National and Kapodistrian University of Athens

Greece

Post-Doctoral Researcher :: Department of Pharmacy

Education History

National and Kapodistrian University of Athens Sep 01 1998 - Sep 01 2005

Greece

PHD :: Department of Pharmacy

National and Kapodistrian University of Athens Sep 01 1998 - Sep 01 2000

Greece

MSC :: Department of Pharmacy

Publications

Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, Maria Georgiou, Athanasios Pousias, Amy Davies, Abigail Pearce, Matthew Harris, George Lamprinidis, Panagiotis Marakos, Nicole Pouli, Antonios D Kolocouris, Nikolaos Lougiakis, Graham Ladds
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. Journal of medicinal chemistry 67 (15) (2024)
Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, Maria Georgiou, Athanasios Pousias, Amy Davies, Abigail Pearce, Matthew Harris, George Lamprinidis, Panagiotis Marakos, Nicole Pouli, Antonios D Kolocouris, Nikolaos Lougiakis, Graham Ladds
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. Journal of medicinal chemistry 67 (15) (2024)
Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, Maria Georgiou, Athanasios Pousias, Amy Davies, Abigail Pearce, Matthew Harris, George Lamprinidis, Panagiotis Marakos, Nicole Pouli, Antonios D Kolocouris, Nikolaos Lougiakis, Graham Ladds
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. Journal of medicinal chemistry (2024)
Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, Maria Georgiou, Athanasios Pousias, Amy Davies, Abigail Pearce, Matthew Harris, George Lamprinidis, Panagiotis Marakos, Nicole Pouli, Antonios D Kolocouris, Nikolaos Lougiakis, Graham Ladds
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. Journal of medicinal chemistry 67 (15) (2024)
Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou, Maria Georgiou, Athanasios Pousias, Amy Davies, Abigail Pearce, Matthew Harris, George Lamprinidis, Panagiotis Marakos, Nicole Pouli, Antonios D Kolocouris, Nikolaos Lougiakis, Graham Ladds
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. Journal of medicinal chemistry 67 (15) (2024)
Panagiota-Efstathia Nikolaou, George Lamprinidis, Maria Georgiou, Dimitrios Karagiannis, Panagiotis Efentakis, Pavlos Bessis-Lazarou, Konstantina Founta, Stavros Kampoukos, Vasilis Konstantin, Carlos M Palmeira, Sean M Davidson, Nikolaos Lougiakis, Panagiotis Marakos, Nicole Pouli, Emmanuel Mikros, Ioanna Andreadou
Hydrolytic Activity of Mitochondrial F 1 F O -ATP Synthase as a Target for Myocardial Ischemia-Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors. Journal of medicinal chemistry (2023)
Bin Tan, Chang Liu, Kan Li, Prakash Jadhav, George Lamprinidis, Lan Zhu, Linda Olson, Haozhou Tan, Yu Wen, Antonios D Kolocouris, Wei Liu, Jun Wang
Structure-Based Lead Optimization of Enterovirus D68 2A Protease Inhibitors. Journal of medicinal chemistry (2023)
Elizabeth Fragopoulou, Katerina Gkotsi, Filio Petsini, Katerina Gioti, Amalia D Kalampaliki, George Lamprinidis, Ioannis K Kostakis, Roxane Tenta
Synthesis and Biological Evaluation of Resveratrol Methoxy Derivatives. Molecules (Basel, Switzerland) 28 (14) (2023)
Dimitrios Bakalis, George Lamprinidis, Angeliki P Kourounakis, George Manis
Contribution of Deep Learning in the Investigation of Possible Dual LOX-3 Inhibitors/DPPH Scavengers: The Case of Recently Synthesized Compounds. Bioengineering (Basel, Switzerland) 9 (12) (2022)
Christos Liolios, Christos Patsis, George Lamprinidis, Efpraxia Tzortzini, Mareike Roscher, Ulrike Bauder-Wüst, Antonios D Kolocouris, Klaus Kopka
Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two Receptors. Molecular pharmaceutics 19 (7) (2022)
Dimitrios Bakalis, George Lamprinidis, Angeliki P Kourounakis, George Manis
Contribution of Deep Learning in the Investigation of Possible Dual LOX-3 Inhibitors/DPPH Scavengers: The Case of Recently Synthesized Compounds. Bioengineering (Basel, Switzerland) 9 (12) (2022)
Argyro Vontzalidou, Sapfo-Maria Dimitrakoudi, Konstantinos Tsoukalas, Grigoris Zoidis, Eliza Chaita, Evanthia Dina, Christina Cheimonidi, Ioannis P Trougakos, George Lamprinidis, Alexios-Leandros Skaltsounis, Emmanuel Mikros, Nektarios Aligiannis
Development of Stilbenoid and Chalconoid Analogues as Potent Tyrosinase Modulators and Antioxidant Agents. Antioxidants (Basel, Switzerland) 11 (8) (2022)
Mostafa A Asmaey, Dennis Abatis, Ahmed S Abdel-Razek, George Lamprinidis, Ioanna Chinou, Nikolas Fokialakis, Nikolaos Tsafantakis, Mohamed Shaaban, Nektarios Aligiannis
Ochraceopyronide, a Rare α-Pyrone-C-lyxofuranoside from a Soil-Derived Fungus Aspergillus ochraceopetaliformis. Molecules (Basel, Switzerland) 26 (13) (2021)
Chunlong Ma, Michael Dominic Sacco, Zilei Xia, George Lamprinidis, Julia Alma Townsend, Yanmei Hu, Xiangzhi Meng, Tommy Szeto, Mandy Ba, Xiujun Zhang, Maura Gongora, Fushun Zhang, Michael Thomas Marty, Yan Xiang, Antonios D Kolocouris, Yu Chen, Jun Wang
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay. ACS central science 7 (7) (2021)
Anna-Maria Fantel, Vassilios Myrianthopoulos, Anastasios Georgoulis, Nikolaos Lougiakis, Iliana Zantza, George Lamprinidis, Fiona Augsburger, Panagiotis Marakos, Constantinos E Vorgias, Csaba Szabó, Nicole Pouli, Andreas Papapetropoulos, Emmanuel Mikros
Screening of Heteroaromatic Scaffolds against Cystathionine Beta-Synthase Enables Identification of Substituted Pyrazolo[3,4-c]Pyridines as Potent and Selective Orthosteric Inhibitors. Molecules (Basel, Switzerland) 25 (16) (2020)
Anezia Kourkoulou, Pothos Grevias, George Lamprinidis, Euan Pyle, Mariangela Dionysopoulou, Argyris Politis, Emmanuel Mikros, Bernadette Byrne, George Diallinas
Specific Residues in a Purine Transporter Are Critical for Dimerization, ER Exit, and Function. Genetics 213 (4) (2019)
Maria Botou, Panayiota Lazou, Konstantinos Papakostas, George Lamprinidis, Thomas Evangelidis, Emmanuel Mikros, Stathis Frillingos
Insight on specificity of uracil permeases of the NAT/NCS2 family from analysis of the transporter encoded in the pyrimidine utilization operon of Escherichia coli. Molecular microbiology 108 (2) (2018)
Panagiotis Lagarias, Eleni Vrontaki, George Lamprinidis, Dimitrios Stamatis, Marino Convertino, Gabriella Ortore, Thomas Mavromoustakos, Karl-Norbert Klotz, Antonios D Kolocouris
Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode. Journal of chemical information and modeling 58 (4) (2018)
Georgia Sioupouli, George Lamprinidis, Emmanuel Mikros, Sotiris Amillis, George Diallinas
Cryptic purine transporters in Aspergillus nidulans reveal the role of specific residues in the evolution of specificity in the NCS1 family. Molecular microbiology 103 (2) (2016)

George Lamprinidis.css-eqlu8i{font-size:small;padding-left:4px;} (George Lambrinidis)

Publication Activity (10 Years)

Top Topics

Top Venues

George Lamprinidis (George Lambrinidis)